Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 374,487 |
|
|||||
| News | (1) | ||||||
| Day High | 235.28 | Low High |
|||||
| Day Low | 228.63 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Madrigal Pharmaceuticals Inc | MDGL | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -5.27 | -2.24% | 229.58 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 234.81 | 228.63 | 235.28 | 229.58 | 234.85 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,507 | 374,487 | US$ 230.63 | US$ 86,369,727 | - | 119.7604 - 300.9999 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:50:05 | 1 | US$ 229.02 | USD |
Madrigal Pharmaceuticals (MDGL) Options Flow Summary
Madrigal Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.57B | 19.90M | - | 0 | -373.63M | -18.78 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Madrigal Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MDGL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 217.53 | 250.34 | 215.02 | 234.35 | 442,443 | 12.05 | 5.54% |
| 1 Month | 192.49 | 250.34 | 189.00 | 218.15 | 421,332 | 37.09 | 19.27% |
| 3 Months | 237.38 | 298.00 | 189.00 | 240.13 | 510,408 | -7.80 | -3.29% |
| 6 Months | 187.12 | 298.00 | 168.2462 | 229.56 | 478,197 | 42.46 | 22.69% |
| 1 Year | 280.68 | 300.9999 | 119.7604 | 208.02 | 433,885 | -51.10 | -18.21% |
| 3 Years | 130.65 | 322.67 | 52.33 | 180.13 | 325,485 | 98.93 | 75.72% |
| 5 Years | 99.24 | 322.67 | 52.33 | 160.08 | 261,011 | 130.34 | 131.34% |
Madrigal Pharmaceuticals Description
| Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. |
